Expression and prognostic value of Mycl1 in gastric cancer

Biochemical and Biophysical Research Communications

Volumn 456, Issue 4, 2015, Pages 879-883

  Chen, Shuqin ^a   Tang, Jianqing ^a   Huang, Liyun ^a   Lin, Jianyin ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

Biomarker; Gastric cancer; Mycl1; Prognostic factor

Indexed keywords

BIOLOGICAL MARKER; MYC PROTEIN; MYCL1 PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG; MYCL1 PROTEIN, HUMAN;

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; MUCOSA; OVERALL SURVIVAL; PRIMARY TUMOR; PRIORITY JOURNAL; STOMACH CANCER; STROMA CELL; TUMOR DIFFERENTIATION; AGED; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; PROGNOSIS; STOMACH; STOMACH TUMOR; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-MYC; STOMACH; STOMACH NEOPLASMS;

EID: 84921282296     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.12.060     Document Type: Article

References (20)

1. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, D. Forman, Global cancer statistics, CA Cancer J. Clin. 61 (2011) 69-90.
2. M.M. Nau, B.J. Brooks, J. Battey, E. Sausville, A.F. Gazdar, I.R. Kirsch, O.W. McBride, V. Bertness, G.F. Hollis, J.D. Minna, L-Myc, a new Myc-related gene amplified and expressed in human small cell lung cancer, Nature 318 (1985) 69-73.
3. E.M. Blackwood, R.N. Eisenman, Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc, Science 251 (1991) 1211-1217.
4. M.D. Cole, S.B. McMahon, The Myc oncoprotein: a critical evaluation of transactivation and target gene regulation, Oncogene 18 (1999) 2916-2924.
5. C.E. Nesbit, J.M. Tersak, E.V. Prochownik, MYC oncogenes and human neoplastic disease, Oncogene 18 (1999) 3004-3016.
6. M.F. Roussel, G.W. Robinson, Role of MYC in medulloblastoma, Cold Spring Harb. Perspect. Med. 3 (2013) 1-15.
7. K.G. Paulson, B.D. Lemos, B. Feng, N. Jaimes, P.F. Peñas, X. Bi, E. Maher, L. Cohen, J.H. Leonard, S.R. Granter, L. Chin, P. Nghiem, Array-CGH reveals recurrent genomic changes in Merkel cell carcinoma including amplification of L-Myc, J. Invest. Dermatol. 129 (2009) 1547-1555.
8. R. Wu, L. Lin, D.G. Beer, L.H. Ellenson, B.J. Lamb, J.M. Rouillard, R. Kuick, S. Hanash, D.R. Schwartz, E.R. Fearon, K.R. Cho, Amplification and overexpression of the L-MYC proto-oncogene in ovarian carcinomas, Am. J. Pathol. 162 (2003) 1603-1610.
9. S.Q. Chen, X.D. Lin, J.W. Zhu, Y. Tang, J.Y. Lin, Association of a MYCL1 single nucleotide polymorphism, rs3134613, with susceptibility to diffuse-type gastric cancer and with differentiation of gastric cancer in a southeast Chinese population, DNA Cell Biol. 29 (2010) 739-743.
10. K. Washington, 7th edition of the AJCC cancer staging manual: stomach, Ann. Surg. Oncol. 17 (2010) 3077-3079.
11. S.D. Morgenbesser, N. Schreiber-Agus, M. Bidder, K.A. Mahon, P.A. Overbeek, J. Horner, R.A. DePinho, Contrasting roles for c-Myc and L-Myc in the regulation of cellular growth and differentiation in vivo, EMBO J. 14 (1995) 743-756.
12. M. Schwab, K. Alitalo, K.H. Klempnauer, H.E. Varmus, J.M. Bishop, F. Gilbert, G. Brodeur, M. Goldstein, J. Trent, Amplified DNA with limited homology to Myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour, Nature 305 (1983) 245-248.
13. J.M. Bishop, The molecular genetics of cancer, Science 235 (1987) 305-311.
14. D. Hanahan, R.A. Weinberg, The hallmarks of cancer, Cell 100 (2000) 57-70.
15. M.A. Sirover, Subcellular dynamics of multifunctional protein regulation: mechanisms of GAPDH intracellular translocation, J. Cell Biochem. 113 (2012) 2193-2200.
16. J.J. Xie, L.Y. Xu, Z.Y. Wu, Q. Zhao, X.E. Xu, J.Y. Wu, Q. Huang, E.M. Li, Prognostic implication of ezrin expression in esophageal squamous cell carcinoma, J. Surg. Oncol. 104 (2011) 538-543.
17. G. Rahir, M. Moser, Tumor microenvironment and lymphocyte infiltration, Cancer Immunol. Immunother. 61 (2012) 751-759.
18. L.L. Cunha, E.C. Morari, A.C. Guihen, D. Razolli, R. Gerhard, S. Nonogaki, F.A. Soares, J. Vassallo, L.S. Ward, Infiltration of a mixture of immune cells may be related to good prognosis in patients with differentiated thyroid carcinoma, Clin. Endocrinol. (Oxf.) 77 (2012) 918-925.
19. K.G. Paulson, J.G. Iyer, W.T. Simonson, A. Blom, R.M. Thibodeau, M. Schmidt, S. Pietromonaco, M. Soki, E.M. Warton, M.M. Asqari, P. Nqhiem, CD8+ lymphocyte intratumoral infiltration as a stage-independent predictor of Merkel cell carcinoma survival: a population-based study, Am. J. Clin. Pathol. 142 (2014) 452-458.
20. W. Kc, A.T. Satpathy, A.S. Rapaport, C.G. Briseño, X. Wu, J.C. Albring, E.V. Russler-Germain, N.M. Kretzer, V. Durai, S.P. Persaud, B.T. Edelson, J. Loschko, M. Cella, P.M. Allen, M.C. Nussenzweig, M. Colonna, B.P. Sleckman, T.L. Murphy, K.M. Murphy, L-Myc expression by dendritic cells is required for optimal T-cell priming, Nature 507 (2014) 243-247.